Imai (1954) The growth of human carcinoma: a morphological analysis. Fukuoka Igaku Zasshi 45:30
Google Scholar
Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID (2020) Tumour budding in solid cancers. Nat Rev Clin Oncol. https://doi.org/10.1038/s41571-020-0422-y
Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, Flejou JF, Hansen TP, Hartmann A, Kakar S, Langner C, Nagtegaal I, Puppa G, Riddell R, Ristimaki A, Sheahan K, Smyrk T, Sugihara K, Terris B, Ueno H, Vieth M, Zlobec I, Quirke P (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30:1299–1311. https://doi.org/10.1038/modpathol.2017.46
Article
PubMed
Google Scholar
Kakar S, Chanjuan S, Mariana BE, Driman DK, Fitzgibbons P, Frankel W, Hill KA, Jessup J, Krasinskas AM, Washington MK (2017) Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. https://documents.cap.org/protocols/cp-gilower-colonrectum-17protocol-4010.pdf. Accessed October 2020
Benson A., Venook AP, Cederquist L ea (2020) National Comprehensive Cancer Network. Clinical practice guidelines in oncology (NCCN guidelines): colon cancer. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed October 2020
Loughrey MB, Arends M, Brown I, Burgart LJ, Cunningham C, Flejou JF, Kakar S, Kirsch R, Kojima M, Lugli A, Rosty C, Sheahan K, West NP, Wilson R, Nagtegaal I (2020) Colorectal cancer histopathology reporting guide. International Collaboration on Cancer Reporting. Sydney, Australia
Lang-Schwarz C, Melcher B, Haumaier F, Schneider-Fuchs A, Lang-Schwarz K, Krugmann J, Vieth M, Sterlacci W (2019) Budding, tumor-infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in World Health Organization low-grade colorectal cancer with impact on survival. Hum Pathol 89:81–89. https://doi.org/10.1016/j.humpath.2019.04.006
Article
PubMed
Google Scholar
Landau MA, Zhu B, Akwuole FN, Pai RK (2019) Histopathological predictors of recurrence in stage III colon cancer: reappraisal of tumor deposits and tumor budding using AJCC8 criteria. Int J Surg Pathol 27:147–158. https://doi.org/10.1177/1066896918787275
CAS
Article
PubMed
Google Scholar
van Wyk HC, Roseweir A, Alexander P, Park JH, Horgan PG, McMillan DC, Edwards J (2019) The relationship between tumor budding, tumor microenvironment, and survival in patients with primary operable colorectal cancer. Ann Surg Oncol 26:4397–4404. https://doi.org/10.1245/s10434-019-07931-6
Article
PubMed
PubMed Central
Google Scholar
Blank A, Schenker C, Dawson H, Beldi G, Zlobec I, Lugli A (2019) Evaluation of tumor budding in primary colorectal cancer and corresponding liver metastases based on H&E and pancytokeratin staining. Front Med (Lausanne) 6:247. https://doi.org/10.3389/fmed.2019.00247
Article
Google Scholar
Dawson H, Galuppini F, Trager P, Berger MD, Studer P, Brugger L, Zlobec I, Inderbitzin D, Lugli A (2019) Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer. Hum Pathol 85:145–151. https://doi.org/10.1016/j.humpath.2018.10.023
Article
PubMed
Google Scholar
Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Matsuda C, Nakamoto Y, Kotake M, Kurachi K, Egawa T, Yasumasa K, Murata K, Ikawa O (2019) Prospective multicenter study on the prognostic and predictive impact of tumor budding in stage II colon cancer: results from the SACURA Trial. J Clin Oncol 37:1886–1894. https://doi.org/10.1200/JCO.18
CAS
Article
PubMed
PubMed Central
Google Scholar
Gordon TJ (1994) The Delphi method. Futur Res Methodol 4:2–15
Google Scholar
Ueno H, Kajiwara Y, Shimazaki H, Shinto E, Hashiguchi Y, Nakanishi K, Maekawa K, Katsurada Y, Nakamura T, Mochizuki H, Yamamoto J, Hase K (2012) New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 32
Oishi K, Ito T, Sakonishi D, Uchida K, Sekine M, Negi M, Kobayashi D, Miura K, Akashi T, Eishi Y (2019) Cancer gland rupture as a potential risk factor for lymph node metastasis in early colorectal adenocarcinoma with deep submucosal invasion. Histopathology. https://doi.org/10.1111/his.14022
Bokhorst JM, Blank A, Lugli A, Zlobec I, Dawson H, Vieth M, Rijstenberg LL, Brockmoeller S, Urbanowicz M, Flejou JF, Kirsch R, Ciompi F, van der Laak J, Nagtegaal ID (2020) Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning. Mod Pathol 33:825–833. https://doi.org/10.1038/s41379-019-0434-2
CAS
Article
PubMed
Google Scholar
Martinez-Ciarpaglini C, Fernandez-Sellers C, Tarazona N, Rosello S, Huerta M, Roda D, Mongort C, Ferrandez A, Navarro S, Cervantes A (2019) Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens. Histopathology 75:517–525. https://doi.org/10.1111/his.13900
Article
PubMed
Google Scholar
Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R (2012) Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol 25:1315–1325. https://doi.org/10.1038/modpathol.2012.94
CAS
Article
PubMed
Google Scholar
Koelzer VH, Zlobec I, Berger MD, Cathomas G, Dawson H, Dirschmid K, Hadrich M, Inderbitzin D, Offner F, Puppa G, Seelentag W, Schnuriger B, Tornillo L, Lugli A (2015) Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study. Virchows Arch 466:485–493. https://doi.org/10.1007/s00428-015-1740-9
CAS
Article
PubMed
Google Scholar
Kai K, Aishima S, Aoki S, Takase Y, Uchihashi K, Masuda M, Nishijima-Matsunobu A, Yamamoto M, Ide K, Nakayama A, Yamasaki M, Toda S (2016) Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer. Pathol Int 66:75–82. https://doi.org/10.1111/pin.12374
CAS
Article
PubMed
Google Scholar
Suzuki A, Togashi K, Nokubi M, Koinuma K, Yasuyuki M, Horie H, Lefor AT, Yasuda Y (2009) Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am J Surg Pathol 33:1601–1607
Article
PubMed
Google Scholar
Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, Wang LM, Langner C, Mitomi H, Nakamura T, Watanabe M, Ueno H, Chasle J, Conley SA, Herlin P, Lauwers GY, Risio M (2012) Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology 61:562–575. https://doi.org/10.1111/j.1365-2559.2012.04270.x
Article
PubMed
Google Scholar
Konishi T, Shimada Y, Lee LH, Cavalcanti MS, Hsu M, Smith JJ, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Vakiani E, Gonen M, Shia J, Weiser MR (2018) Poorly differentiated clusters predict colon cancer recurrence: an in-depth comparative analysis of invasive-front prognostic markers. Am J Surg Pathol 42:705–714. https://doi.org/10.1097/PAS.0000000000001059
Article
PubMed
PubMed Central
Google Scholar
Lai YH, Wu LC, Li PS, Wu WH, Yang SB, Xia P, He XX, Xiao LB (2014) Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer. Color Dis 16:259–264. https://doi.org/10.1111/codi.12454
Article
Google Scholar
Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A (2013) Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol 44:697–705. https://doi.org/10.1016/j.humpath.2012.07.026
Article
PubMed
Google Scholar
Karamitopoulou E, Zlobec I, Kolzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A (2013) Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer. Mod Pathol 26:295–301. https://doi.org/10.1038/modpathol.2012.155
CAS
Article
PubMed
Google Scholar
Martin B, Schafer E, Jakubowicz E, Mayr P, Ihringer R, Anthuber M, Schenkirsch G, Schaller T, Markl B (2018) Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance? Virchows Arch 473:189–197. https://doi.org/10.1007/s00428-018-2341-1
Article
PubMed
Google Scholar
Zlobec I, Berger MD, Lugli A (2020) Tumour budding and its clinical implications in gastrointestinal cancers. Br J Cancer. https://doi.org/10.1038/s41416-020-0954-z
Cappellesso R, Luchini C, Veronese N, Lo Mele M, Rosa-Rizzotto E, Guido E, De Lazzari F, Pilati P, Farinati F, Realdon S, Solmi M, Fassan M, Rugge M (2017) Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis. Hum Pathol 65:62–70. https://doi.org/10.1016/j.humpath.2017.04.013
CAS
Article
PubMed
Google Scholar
Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K, Japanese Society for Cancer of the C, Rectum (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42. https://doi.org/10.1007/s10147-019-01485-z
Article
PubMed
Google Scholar
Bosch SL, Teerenstra S, de Wilt JH, Cunningham C, Nagtegaal ID (2013) Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy 45:827–834. https://doi.org/10.1055/s-0033-1344238
Article
PubMed
Google Scholar
Petrelli F, Pezzica E, Cabiddu M, Coinu A, Borgonovo K, Ghilardi M, Lonati V, Corti D, Barni S (2015) Tumour budding and survival in stage II colorectal cancer: a systematic review and pooled analysis. J Gastrointest Cancer 46:212–218. https://doi.org/10.1007/s12029-015-9716-1
CAS
Article
PubMed
Google Scholar
Okuyama T, Nakamura T, Yamaguchi M (2003) Budding is useful to select high-risk patients in stage II well differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum 46:1400–1406
Article
PubMed
Google Scholar
Hayes BD, Maguire A, Conlon N, Gibbons D, Wang LM, Sheahan K (2010) Reproducibility of the rapid bud count method for assessment of tumor budding in stage II colorectal cancer. Am J Surg Pathol 34:746–748
Article
PubMed
Google Scholar
Betge J, Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Vieth M, Langner C (2012) Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer. Ann Surg Oncol 19:3706–3712. https://doi.org/10.1245/s10434-012-2426-z
Article
PubMed
Google Scholar
Canney AL, Kevans D, Wang LM, Hyland JM, Mulcahy HE, O'Donoghue DP, O'Sullivan J, Geraghty R, Sheahan K (2012) Stage II colonic adenocarcinoma: a detailed study of pT4N0 with emphasis on peritoneal involvement and the role of tumour budding. Histopathology 61:488–496. https://doi.org/10.1111/j.1365-2559.2012.04250.x
Article
PubMed
Google Scholar
Group QC (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370:2020–2029. https://doi.org/10.1016/s0140-6736(07)61866-2
Article
Google Scholar
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Kohne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23:2479–2516. https://doi.org/10.1093/annonc/mds236
CAS
Article
PubMed
Google Scholar
Shivji S, Conner J, Barresi V, Kirsch R (2020) Poorly differentiated clusters in colorectal cancer: a current review and implications for future practice. Histopathology. https://doi.org/10.1111/his.14128
Hong M, Kim JW, Shin MK, Kim BC (2017) Poorly differentiated clusters in colorectal adenocarcinomas share biological similarities with micropapillary patterns as well as tumor buds. J Korean Med Sci 32:1595–1602. https://doi.org/10.3346/jkms.2017.32.10.1595
CAS
Article
PubMed
PubMed Central
Google Scholar
Barresi V, Branca G, Vitarelli E, Tuccari G (2014) Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: a proposal for a change in terminology. Am J Clin Pathol 142:375–383. https://doi.org/10.1309/AJCPFEA7KA0SBBNA
Article
PubMed
Google Scholar
Studer L, Blank A, Bokhorst JM, Nagtegaal ID, Zlobec I, Lugli A, Fischer A, Dawson H (2020) Taking tumour budding to the next frontier - a post-ITBCC 2016 review. Histopathology. https://doi.org/10.1111/his.14267
Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I (2011) Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Hum Pathol 42:1833–1840. https://doi.org/10.1016/j.humpath.2011.02.010
Article
PubMed
Google Scholar